Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Vigabatrin is an anticonvulsant. It is known to work by stopping the breakdown of a natural calming substance (GABA) in the brain
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
The company has started manufacturing the Sputnik Light vaccine
FDA changes inspection classification of the facility to Voluntary Action Indicated
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
An MoU was signed between B Medical Systems and Gujarat government recently
This is the fourth facility from the company to receive this registration
Subscribe To Our Newsletter & Stay Updated
